Chilblains, an Indirect Dermatological Consequence of the COVID-19 Pandemic

JAMA Dermatology

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 25, 2020

Media advisory: The full article and editor’s note are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2020.2368?guestAccessKey=598ec7d6-da3d-4fb1-b9ee-8ce5c673376a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062520

 

What The Study Did: The possible association between chilblains and COVID-19 was investigated in this case series that included 31 patients.

Authors: Anne Herman, M.D., of the Université Catholique de Louvain in Brussels, is the corresponding author.

 

(doi:10.1001/jamadermatol.2020.2368)

Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.